Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 25046 | 2-Propynamide, 3-[(3Z)-3-[[[4-[(dimethylamino)methyl]phenyl]amino]phenylmethylene]-2,3-dihydro-2-oxo-1H-indol-6-yl]-N-ethyl- | 2128698-24-6 | 98% Min. |  |
| 24155 | Phylloflavan | 98570-83-3 | 98% Min. |  |
| Phylloflavan is an antileishmanial agent with an intracellular EC50 of 3.2 nM in RAW | ||||
| 24140 | PST3 1a | 1096144-06-7 | 98% Min. |  |
| PST3 1a is a Novel selective inhibitor of the N-acetylglucosamine glycosyltransferase | ||||
| 24128 | PFI-2 free base | 1627676-59-8 | 98% Min. |  |
| PFI-2 is a potent inhibitor of SETD7 with IC50 2 nM and 1000-fold selectivity over ot | ||||
| 24111 | PLX-4545 | 2892065-45-9 | ≧98.0% |  |
| PLX-4545 is an orally bioavailable molecular glue degrader of IKZF2 designed to desta | ||||
| 24081 | Pyrazolo[1,5-a]pyrimidine, 7-chloro-5-(1-ethylpropyl)- | 2416875-06-2 | 98% Min. | -_2416875-06-2.png) |
| 24079 | Povorcitinib | 1637677-22-5 | 98% Min. |  |
| Povorcitinib is a Janus kinase inhibitor that also displays anti-inflammatory activit | ||||
| 24067 | PBT434 Hydrobromide | 1232841-78-9 | ≧98.0% |  |
| PBT434, also known as ATH434 , is a novel, brain-penetrant, inhibitor of α-synuclein | ||||
| 25077 | PHGDH-IN-3 | 2893778-31-7 | 98% Min. |  |
| PHGDH-IN-3 is an orally active phosphoglycerate dehydrogenase (PHGDH) inhibitor. | ||||
| 24037 | Pico145 | 1628287-16-0 | 98% Min. | _1628287-16-0.png) |
| Pico145 (HC-608) is a remarkable inhibitor ofTRPC1/4/5channels, inhibits (−)-engler | ||||
| 24056 | proTAME | 1362911-19-0 | ≧95.0%+ |  |
| ProTAME is Small molecule inhibitors of the APC/C. | ||||
| 20624 | Pitolisant HCl | 903576-44-3 | 98% Min. |  |
| Pitolisant, also known as Tiprolisant, BF2649 and Ciproxidine, is a histamine recepto | ||||
| 20618 | Pirtobrutinib | 2101700-15-4 | 98% Min. |  |
| 20613 | PLX8394 | 1393466-87-9 | 98% Min. | _1393466-87-9.png) |
| PLX8394 is an orally bioavailable inhibitor of serine/threonine-protein kinase B-raf | ||||
| 231106 | PDS-0330 | 2904682-19-3 | ≧98.0% |  |
| PDS0330 is a new claudin-1 inhibitor in Colorectal Cancer. | ||||
| 20548 | Pimicotinib ( ABSK02 ) | 2253123-16-7 | ≧98.0% |  |
| Pimicotinib is a novel small molecule inhibitor of CSF-1R, which is orally available, | ||||
| 20527 | PF-9363 | 98% Min. |  | |
| 20511 | PDD4091 | 1373651-41-2 | ≧98.0% |  |
| PDD4091 is a novel G6PD inhibitor. | ||||
| 20500 | PD089828 | 179343-17-0 | 98% Min. |  |
| PD089828 is a potent FGFR inhibitor, which inhibits human full-length fibroblast grow | ||||
| 20499 | PD-173955 | 260415-63-2 | 98% Min. |  |
| PD-173955 is a src tyrosine kinase inhibitor. PD173955 inhibited Bcr-Abl-dependent ce | ||||
| 20481 | 4-Pyrimidinol, 6-cyclopropyl- (7CI,8CI) | 7038-75-7 | 98% Min. | _7038-75-7.png) |
| 20468 | PD-173212 | 217171-01-2 | 98% Min. |  |
| PD-173212 is a small molecule N-type calcium channel blocker. PD173212 fully reduced | ||||
| 20432 | 2-Pyridinamine, 3-(difluoromethoxy)-5-[2-(3,3-difluoro-1-pyrrolidinyl)-6-(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl-4-pyrimidinyl]- | 1637394-01-4 | 98% Min. | -5-[2-(3,3-difluoro-1-pyrrolidinyl)-6-(1S,4S)-2-oxa-5-azabicyclo[2.2.1]hept-5-yl-4-pyrimidinyl]-_1637394-01-4.png) |
| 20399 | 5-(1-propyloxy)-pyrrolidin-2-one | 111712-03-9 | 98% Min. | -pyrrolidin-2-one_111712-03-9.png) |
| G20374 | 1-Piperazinecarboxylic acid, 2-methyl-5-oxo-, 1,1-dimethylethyl ester, (2S)- | 1627749-02-3 | 98% Min. |  |
| 20367 | Piflufolastat | 1423758-00-2 | ≧96% |  |
| Piflufolastat, also known as DCFPYL is a PSMA-targeted PET imaging agent for prostate | ||||
| L20351 | PFM01 | 1558598-41-6 | 98% Min. |  |
| PFM01 is a nuclease-specific MRE11 inhibitor. PFM01 targets MRE11 at a site near the | ||||
| L20349 | Poloxin | 321688-88-4 | 98% Min. |  |
| Poloxin is the first small-molecule inhibitor specifically targeting the function of | ||||
| L20345 | Prexasertib free base | 1234015-52-1 | 98% Min. |  |
| Prexasertib, also know LY2606368, is a n inhibitor of checkpoint kinase 1 (chk1) with | ||||
| L20333 | Parsaclisib HCl | 1995889-48-9 | 98% Min. |  |
| Parsaclisib, also known as INCB050465, is a novel PI3Kδ inhibitor which synergizes w | ||||